Clinical Trial Update: A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [Phase 2]

View source ↗

Summary

A Phase 2 randomized study compares LY3457263 to placebo in adults with Type 2 diabetes mellitus who are on a stable dose of semaglutide or tirzepatide; recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• LY3457263 (LY3457263)
• Tirzepatide (tirzepatide)
• semaglutide (semaglutide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 2 | Status: RECRUITING